SWA
IMGN

Stratos Wealth Advisors’s Immunogen Inc IMGN Stock Holding History

Stratos Wealth Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,639
Closed -$31K – 254
2019
Q3 		$31K Sell
12,639
-126
-1% -$335 0.01% 246
2019
Q2 		$28K Sell
12,765
-1,259
-9% -$2.98K 0.01% 232
2019
Q1 		$38K Buy
+14,024
New +$60.7K 0.02% 213

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Stratos Wealth Advisors's IMGN Position: Q4 2019 in Review

Stratos Wealth Advisors sold out of Immunogen Inc (IMGN) in Q4 2019, closing a stake of 12,639 shares — an estimated $31K sold.

Stratos Wealth Advisors first reported a position in IMGN in Q1 2019 and held it in 3 quarters. The position peaked at $38K in Q1 2019. 191 funds tracked by Wall St. Rank hold IMGN as of Q4 2019.

  • Stratos Wealth Advisors reported no remaining Immunogen Inc position as of Q4 2019 after selling out during the quarter.
  • Stratos Wealth Advisors sold 12,639 Immunogen Inc shares in Q4 2019, an estimated $31K.
  • Stratos Wealth Advisors first reported a position in Immunogen Inc in Q1 2019 and held it in 3 quarters.
  • Stratos Wealth Advisors's Immunogen Inc position peaked at $38K in Q1 2019.
  • 191 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2019.

Based on Stratos Wealth Advisors's 13F filing for Q4 2019, filed 29 Jan 2020.